早期高氯血症与脑出血患者死亡或残疾独立相关
本研究基于抗高血压治疗脑出血2试验(ATACH-2)数据,分析1000例自发性脑出血患者,定义基线或随机化后24、48、72小时血清氯≥110 mmol/L为高氯血症,并分为1次和≥2次发生。调整年龄、种族和民族、美国国立卫生研究院卒中量表评分分层、血肿体积、脑室内出血、吸烟、既往卒中及尼卡地平最大每小时剂量后,1次高氯血症(OR 2.5,95%CI 1.1-5.5)和≥2次高氯血症(OR 2.6,95%CI 1.3-5.0)患者90天死亡风险显著增高;≥2次高氯血症患者90天死亡或残疾风险显著增高(OR 3.4,95%CI 2.1-5.6)。作者认为避免高氯血症可能减少脑出血患者死亡或残疾。
要点
- 自发性脑出血发病4.5小时内入组,基线或随机化后24、48、72小时血清氯≥110 mmol/L定义为高氯血症。
- 1000例中,72小时内高氯血症发生1次者114例,≥2次者154例。
- 调整混杂因素后,高氯血症1次者90天死亡OR 2.5(95%CI 1.1-5.5),≥2次者OR 2.6(95%CI 1.3-5.0)。
- 高氯血症≥2次者90天死亡或残疾OR 3.4(95%CI 2.1-5.6),与无高氯血症者相比。
- 作者认为避免高氯血症可能减少脑出血患者90天死亡或残疾。
适用人群与场景
- 自发性脑出血发病4.5小时内入组的患者(ATACH-2试验人群)。
诊断标准与关键阈值
- 高氯血症定义为基线或随机化后24、48或72小时血清氯≥110 mmol/L。
- 高氯血症分级:72小时内发生1次或≥2次。
研究设计与关键结果
- 研究类型:基于ATACH-2试验数据的分析;样本量1000例;人群为自发性脑出血发病4.5小时内患者。
- 高氯血症发生情况:72小时内1次者114例,≥2次者154例。
- 主要终点:调整年龄、种族和民族、NIHSS评分分层、血肿体积、脑室内出血、吸烟、既往卒中及尼卡地平最大每小时剂量后,高氯血症1次者90天死亡OR 2.5(95%CI 1.1-5.5),≥2次者OR 2.6(95%CI 1.3-5.0)。
- 主要终点:调整上述混杂因素后,高氯血症≥2次者90天死亡或残疾OR 3.4(95%CI 2.1-5.6),与无高氯血症者相比。
证据类型、等级与局限
- 证据类型:基于随机对照试验ATACH-2数据的二次分析;局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,高氯血症与90天死亡或残疾的独立关联提示避免高氯血症可能减少脑出血患者观察到的死亡或残疾。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: On the basis of increased mortality associated with hyperchloremia among critically ill patients, we investigated the effect of occurrence of early hyperchloremia on death or disability at 90 days in patients with intracerebral hemorrhage (ICH).
METHODS: We analyzed the data from Antihypertensive Treatment of Cerebral Hemorrhage 2 trial, which recruited patients with spontaneous ICH within 4.5 h of symptom onset. Patients with increased serum chloride levels (110 mmol/L or greater) at either baseline or 24, 48, or 72 h after randomization were identified. We further graded hyperchloremia into one occurrence or two or more occurrences within the first 72 h. Two logistic regression analyses were performed to determine the effects of hyperchloremia on (1) death within 90 days and (2) death or disability at 90 days after adjustment for potential confounders.
RESULTS: Among the total of 1,000 patients analyzed, hyperchloremia within 72 h was seen in 114 patients with one occurrence and in 154 patients with two or more occurrences. Patients with one occurrence of hyperchloremia (odds ratio [OR] 2.5, 95% confidence interval [CI] 1.1-5.5) and those with two or more occurrences (OR 2.6, 95% CI 1.3-5.0) had significantly higher odds of death within 90 days after adjustment for age, race and ethnicity, National Institutes of Health Stroke Scale score strata, hematoma volume, presence or absence of intraventricular hemorrhage, cigarette smoking, previous stroke, and maximum hourly dose of nicardipine. Patients with two or more occurrences of hyperchloremia (OR 3.4, 95% CI 2.1-5.6) had significantly higher odds of death or disability at 90 days compared with patients without hyperchloremia after adjustment for the abovementioned potential confounders.
CONCLUSIONS: The independent association between hyperchloremia and death or disability at 90 days suggests that avoidance of hyperchloremia may reduce the observed death or disability in patients with ICH.
CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov: NCT01176565.
参考来源
- Qureshi AI, Huang W, Hanley DF, et al. Early Hyperchloremia is Independently Associated with Death or Disability in Patients with Intracerebral Hemorrhage. Neurocrit Care. 2022. PMID: 35513751. doi:10.1007/s12028-022-01514-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。